California Mental Health Agency Director To Resign Following Conflict of Interest Allegations

California’s mental health commission on Thursday announced its executive director would resign amid revelations that he traveled to the U.K. courtesy of a state vendor while he sought to prevent a budget cut that would have defunded the company’s contract. Toby Ewing, executive director of the Mental Health Services Oversight and Accountability Commission, will step…

Read More

Health Care’s Endless Loops

By KIM BELLARD Last week the Federal Trade Commission (FTC) issued its final “click-to-cancel” rule, making it easier for consumers to cancel various kinds of subscriptions, such as gym memberships or streaming services. It will require enrollments to be as easy to cancel as they were to enroll. “Too often, businesses make people jump through…

Read More

4 Things That Worry FDA Commissioner Robert Califf

This week at HLTH, FDA Commissioner Robert Califf discussed the current state of healthcare AI. He talked about some of the qualms he has, such as his worry that AI is worsening health inequities and his concern that providers aren’t capable of validating AI tools’ effectiveness. The post 4 Things That Worry FDA Commissioner Robert…

Read More

THCB Gang — DiME Special Episode 141, Thursday October 24

Joining Matthew Holt (@boltyboy) on #THCBGang on Thursday October 24 at 1pm PST 4pm EST are Digital Medicine Society CEO Jennifer Goldsack, (@GoldsackJen) , the VA’s Cole Zanetti (@ColeZanetti); and the Chief Commercial Officer at Curai Health Nicole Bell (@bellnicolee). There’ll likely be chatter about #HLTH2024 but also a lot of focus on the new…

Read More

The Convergence of Digital Health and Life Sciences

Despite the challenges of interoperability, regulatory compliance, technology adoption, and data privacy, the benefits of digital health are undeniable. Collaboration between policymakers, clinicians, IT developers, and patients, can help overcome these obstacles. The post The Convergence of Digital Health and Life Sciences appeared first on MedCity News.

Read More

Targeting the Blast Radius: Why Spatial AI Diagnostics Are Crucial for Maximizing the Impact of Antibody-Drug Conjugates

As the field of oncology evolves, we need to shift away from traditional binary “yes-no” biomarkers to a more nuanced, spatial understanding of tumor biology. This approach will allow for more personalized treatment plans that are tailored to the unique characteristics of each patient’s tumor. The post Targeting the Blast Radius: Why Spatial AI Diagnostics…

Read More